Regeneron Pharmaceuticals (REGN) Cash & Equivalents (2009 - 2026)
Regeneron Pharmaceuticals (REGN) reported Cash & Equivalents of $2.46 billion for Q2 2026, up 23.0% from $2 billion a year earlier but down 17.1% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals posted Cash & Equivalents of $3.12 billion, up 25.3% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $2.49 billion in FY2024 (-8.9%), $2.73 billion in FY2023 (-12.1%), $3.11 billion in FY2022 (+7.6%) and $2.89 billion in FY2021 (+31.5%).
- Five-year quarterly Cash & Equivalents spans a low of $1.92 billion in Q2 2024 and a high of $3.92 billion in Q1 2023.
- Year over year, Cash & Equivalents gained in five of the last eight quarters, with growth averaging 9.5%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2022 (growth of 132.7%); the low point was Q2 2023 (a decline of 42.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.96 billion (Q1 2026), $3.12 billion (Q4 2025) and $2.51 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 2.46 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.46 Bn |
| Mar 31, 2026 | 2.96 Bn |
| Dec 31, 2025 | 3.12 Bn |
| Sep 30, 2025 | 2.51 Bn |
| Jun 30, 2025 | 2.00 Bn |
| Mar 31, 2025 | 3.09 Bn |
| Dec 31, 2024 | 2.49 Bn |
| Sep 30, 2024 | 2.01 Bn |
| Jun 30, 2024 | 1.92 Bn |
| Mar 31, 2024 | 2.60 Bn |
| Dec 31, 2023 | 2.73 Bn |
| Sep 30, 2023 | 2.15 Bn |
| Jun 30, 2023 | 1.94 Bn |
| Mar 31, 2023 | 3.92 Bn |
| Dec 31, 2022 | 3.11 Bn |
| Sep 30, 2022 | 3.49 Bn |
| Jun 30, 2022 | 3.40 Bn |
| Mar 31, 2022 | 3.35 Bn |
| Dec 31, 2021 | 2.89 Bn |
| Sep 30, 2021 | 3.43 Bn |
API Access
Regeneron Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();